Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: January 2013
-
By Donald Zuhn — In a Federal Register notice published earlier today (78 Fed. Reg. 2256), the U.S. Patent and Trademark Office announced that the Extended Missing Parts Pilot Program that was implemented two years ago would be extended for another year. The pilot program allows applicants to request a twelve-month extension to pay the…
-
By Andrew Williams — Late last year, in AstraZeneca v. Aurobindo (In re Rosuvastatin Calcium Patent Litigation), the Federal Circuit affirmed that a reissue patent covering the active ingredient of Crestor® was valid, enforceable, and infringed by all parties. In so doing, the Court discussed what it meant to be the submitter of an ANDA…
-
By Donald Zuhn — USPTO and EPO Announce Formal Launch of Cooperative Patent Classification System On January 2, both the U.S. Patent and Trademark Office and European Patent Office announced the formal launch of the Cooperative Patent Classification (CPC) system, a global classification system for patent documents (see USPTO press release and EPO press release). …
-
By Donald Zuhn — In an order issued earlier today, the Supreme Court denied certiorari in Sherley v. Sebelius, ending the efforts by two adult stem cell researchers to prevent the National Institutes of Health (NIH) from funding research using human embryonic stem cells (ESCs). The dispute arose following the NIH's release in July 2009…
-
EPO Board of Appeal Decision T1839/11 By Christopher Bond — Background The patent Following grant of a patent to Novozymes in November 2009, the patent was asserted in Denmark, Germany, the Netherlands and the UK. Danisco filed an opposition in March 2010. An opposition division revoked the patent in July 2011 and an EPO board…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Life Technologies Corp. et al. v. Kappos et al.1:12-cv-01518; filed December 28, 2012 in the Eastern District of Virginia • Plaintiffs: Life Technologies Corp.; Geneart AG; Applied Biosystems, LLC• Defendants: David J. Kappos; Office of…
-
January 10, 2013 – China's Patent Regime and its Quest to Become an Innovation Economy (The George Washington University Law School and Fordham University School of Law) – Washington, DC January 10, 2013 – European Unitary Patent: An Update (Intellectual Property Owners Association) – 1:00 – 2:00 pm (ET) January 16, 2013 – European biotech…
-
American Conference Institute (ACI) will be holding its 3rd Advanced Summit on Medical Device Patents on March 5-6, 2013 in Chicago, IL. The conference will allow attendees to: • Integrate the monumental changes under the AIA including first-to-file and patent validity assessment at the PTO into their medical device patents practice;• Prepare for the fallout…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "European Unitary Patent: An Update" on January 10, 2013 beginning at 1:00 pm (ET). A panel consisting of Margot Fröhlinger, Principal Director for patent law and international affairs at the European Patent Office; Paul Coletti, Assistant Patent Counsel for Johnson & Johnson; and…
-
D Young & Co will be offering its next European biotech patent law update on January 16, 2013. The 45-minute webinar will be offered at three times: 4:00 am, 7:00 am, 12:00 pm (EDT). Simon O'Brien and Robert Dempster will provide an essential update and live Q&A on EPO biotechnology case law. While there is…
Patent Docs 